The Macerich Company
NYSE:MACREIT - Retail
+$0.48 today
- Market cap
- $7.22B
- Beta
- 2.09
- P/E (TTM)
- -33.0
- EPS (TTM)
- -$0.71
- Dividend yield
- 2.90%
Volume 3.78M
Average 2.95M
MAC EBITDA Margin
EBITDA as a percentage of revenue.
The Macerich CompanyNYSE: MAC
EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026
EBITDA Margin widens to 52.4%
EBITDA Margin was 52.4% in Q2 FY2026, up 3.8 pp from a year earlier. On a trailing-twelve-month basis it was 40.5%, up 28.8 pp year over year. Over 3 fiscal years it narrowed by 12.8 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 45.7% for the fiscal year ending Dec 2026, up from 40.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 52.4%+9.5 pp QoQ
- Last fiscal yearDec 2025
- 40.1%+4.5 pp YoY
- LTMJun 2026
- 40.5%+28.8 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.8 pp | +59.3 pp | +55.5 pp |
| 1 year | +4.5 pp | +5.6 pp | +1.0 pp |
| 3 years | -12.8 pp | +4.9 pp | +17.7 pp |
| 5 years | -5.6 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 40.1%
- Year-over-year change
- +4.5pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 40.1% | +4.5pp |
| FY2024 | 2024-12-31 | 35.6% | +14.0pp |
| FY2023 | 2023-12-31 | 21.6% | -31.4pp |
| FY2022 | 2022-12-31 | 53.0% | -10.8pp |
| FY2021 | 2021-12-31 | 63.7% | — |
EBITDA Margin vs competitors
How MAC compares with its peers on the latest reported figures
- MAC's LTM Jun 2026 EBITDA Margin of 40.5% is the lowest of the 3 companies compared; the peer median is 100.0%.
- Its year-over-year change of +28.8 pp is the 2nd highest of 3, against a peer median of +25.0 pp.
- Over three fiscal years its change of -12.8 pp compares with a peer median of +26.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 113.9% | +34.7 pp | +37.9 pp | |
| LTM Mar 2026 | 86.1% | +15.3 pp | +15.4 pp | |
| LTM Jun 2026 | 40.5% | +28.8 pp | -12.8 pp | |
| Peer median (excluding MAC) | 100.0% | +25.0 pp | +26.6 pp | |
Competitors are the stored peer set for MAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 847.44M | 859.16M | 884.07M | 918.2M | 1.02B |
| Cost of Revenue | 380.88M | 390.35M | 394.89M | 430.27M | 627.83M |
| Gross Profit | 466.55M | 468.81M | 489.18M | 487.94M | 387.47M |
| Gross Margin | 55.1% | 54.6% | 55.3% | 53.1% | 38.2% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 30.06M | 27.16M | 29.24M | 28.15M | 31.54M |
| Operating Expenses | 341.19M | 318.78M | 311.6M | 322.93M | 219.71M |
| Depreciation & Amortization | 324.4M | 302.48M | 296.39M | 305.88M | 368.1M |
| EBITDA | 540.19M | 454.96M | 190.72M | 326.9M | 407.51M |
| EBITDA Margin | 63.7% | 53.0% | 21.6% | 35.6% | 40.1% |
| Operating Income | 125.37M | 150.04M | 177.58M | 165.01M | 167.76M |
| Operating Margin | 14.8% | 17.5% | 20.1% | 18.0% | 16.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 192.68M | 216.85M | 172.92M | 219.99M | 216.34M |
| Other Income / Expenses | (102.26M) | (214.41M) | (456.17M) | (363.98M) | (344.7M) |
| Income Before Tax | 23.11M | (64.37M) | (278.59M) | (198.97M) | (176.94M) |
| Pre-Tax Margin | 2.7% | -7.5% | -31.5% | -21.7% | -17.4% |
| Income Tax Expense | 6.95M | 705K | (494K) | (1.3M) | (2.19M) |
| Net Income | 14.26M | (66.07M) | (274.07M) | (194.12M) | (197.15M) |
| Net Margin | 1.7% | -7.7% | -31.0% | -21.1% | -19.4% |
| EPS (Basic) | 0.07 | (0.31) | (1.28) | (0.79) | (0.77) |
| EPS (Diluted) | 0.07 | (0.31) | (1.28) | (0.78) | (0.77) |
| Weighted Avg Shares | 198.07M | 215.03M | 215.55M | 244.81M | 256.62M |
| Weighted Avg Shares (Diluted) | 198.07M | 215.03M | 215.55M | 249.75M | 256.62M |
The Macerich Company
NYSE:MAC
Intrinsic Alpha fair value
Locked
Current Price
$24.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.